Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

You may be eligible if

• With definitive pathological results of epithelial ovarian cancer
• With an Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2
• Aged 18 or older
• Receiving 3-4 weeks per cycle of platinum-based chemotherapy with or without debulking surgery
• Regularly followed up in the study centers
• Provided consent for participation.
• Non-compliance with the study protocols
• With a history of chemotherapy or pelvic radiotherapy for malignancies
• Presence of immunosuppressive diseases such as organ transplantation or acquired immune deficiency syndrome
• Treated with weekly chemotherapy regimens
• Presence of hematological disorders